For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell
When the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal suddenly looked treatable, perhaps even curable.
Oct 16, 2018
0
2